Dr. Michelle Williams, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,423 | 6 | 92.0% |
| Food and Beverage | $659.49 | 14 | 4.2% |
| Travel and Lodging | $598.20 | 3 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $11,490 | 6 | $0 (2021) |
| Roche Diagnostics Corporation | $3,902 | 10 | $0 (2018) |
| Merck Sharp & Dohme LLC | $188.49 | 3 | $0 (2024) |
| Medline Industries LP | $51.19 | 2 | $0 (2024) |
| BeiGene USA, Inc. | $29.43 | 1 | $0 (2023) |
| Abbott Laboratories | $19.34 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.12 | 2 | Merck Sharp & Dohme LLC ($73.37) |
| 2023 | $53.87 | 2 | BeiGene USA, Inc. ($29.43) |
| 2021 | $8,336 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($8,336) |
| 2020 | $3,088 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($3,088) |
| 2019 | $66.99 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($66.99) |
| 2018 | $3,922 | 11 | Roche Diagnostics Corporation ($3,902) |
| 2017 | $115.12 | 2 | Merck Sharp & Dohme Corporation ($115.12) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Food and Beverage | In-kind items and services | $73.37 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2024 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $26.75 | General |
| 07/27/2023 | MEDLINE INDUSTRIES LP | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 07/11/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Oncology | ||||||
| 09/13/2021 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $4,940.00 | General |
| Category: Oncology | ||||||
| 07/15/2021 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,543.75 | General |
| Category: Oncology | ||||||
| 01/26/2021 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,852.00 | General |
| Category: Oncology | ||||||
| 11/17/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,235.00 | General |
| Category: Oncology | ||||||
| 04/06/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,852.50 | General |
| Category: Oncology | ||||||
| 03/02/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $66.99 | General |
| Category: Oncology | ||||||
| 12/05/2018 | Roche Diagnostics Corporation | TD VENTANA Primary Staining Instruments and Reagents (Device) | Travel and Lodging | In-kind items and services | $241.92 | General |
| Category: Tissue Diagnostics | ||||||
| 12/05/2018 | Roche Diagnostics Corporation | TD VENTANA Primary Staining Instruments and Reagents (Device) | Food and Beverage | In-kind items and services | $121.03 | General |
| Category: Tissue Diagnostics | ||||||
| 12/05/2018 | Roche Diagnostics Corporation | TD VENTANA Primary Staining Instruments and Reagents (Device) | Food and Beverage | In-kind items and services | $62.70 | General |
| Category: Tissue Diagnostics | ||||||
| 12/05/2018 | Roche Diagnostics Corporation | TD VENTANA Primary Staining Instruments and Reagents (Device) | Food and Beverage | In-kind items and services | $55.13 | General |
| Category: Tissue Diagnostics | ||||||
| 12/05/2018 | Roche Diagnostics Corporation | TD VENTANA Primary Staining Instruments and Reagents (Device) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Tissue Diagnostics | ||||||
| 12/05/2018 | Roche Diagnostics Corporation | TD VENTANA Primary Staining Instruments and Reagents (Device) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Tissue Diagnostics | ||||||
| 12/04/2018 | Roche Diagnostics Corporation | TD BenchMark IHC/ISH and Special Stains Reagents (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Tissue Diagnostics | ||||||
| 12/04/2018 | Roche Diagnostics Corporation | TD BenchMark IHC/ISH and Special Stains Reagents (Device) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Tissue Diagnostics | ||||||
| 12/04/2018 | Roche Diagnostics Corporation | TD BenchMark IHC/ISH and Special Stains Reagents (Device) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Tissue Diagnostics | ||||||
| 11/05/2018 | Roche Diagnostics Corporation | TD BenchMark IHC/ISH and Special Stains Reagents (Device) | Travel and Lodging | Cash or cash equivalent | $312.28 | General |
| Category: Tissue Diagnostics | ||||||
| 05/11/2018 | Abbott Laboratories | Optis Coronary Imaging System (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/31/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $106.98 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2017 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,387 | 2,598 | $933,169 | $98,386 |
| 2022 | 17 | 1,350 | 2,423 | $868,503 | $98,337 |
| 2021 | 15 | 1,322 | 2,411 | $814,210 | $99,356 |
| 2020 | 14 | 780 | 1,647 | $565,341 | $71,515 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 139 | 309 | $182,724 | $19,732 | 10.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 151 | 391 | $177,431 | $18,923 | 10.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 267 | 619 | $219,752 | $17,726 | 8.1% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 200 | 209 | $66,776 | $13,185 | 19.7% |
| 88332 | Pathology examination of specimen during surgery, each additional tissue block | Facility | 2023 | 73 | 261 | $80,683 | $6,296 | 7.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 78 | 263 | $51,512 | $5,767 | 11.2% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 37 | 38 | $30,024 | $4,336 | 14.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 130 | 156 | $39,039 | $4,156 | 10.6% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 84 | 95 | $33,083 | $3,051 | 9.2% |
| 88323 | Surgical pathology consultation and report on referred material requiring preparation of slides | Facility | 2023 | 29 | 29 | $10,618 | $1,864 | 17.6% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 45 | 46 | $16,525 | $1,531 | 9.3% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 63 | 64 | $9,764 | $994.57 | 10.2% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 27 | 40 | $4,645 | $392.33 | 8.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 21 | 29 | $5,931 | $260.89 | 4.4% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 43 | 49 | $4,662 | $170.83 | 3.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 151 | 395 | $223,987 | $26,198 | 11.7% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 163 | 343 | $149,705 | $17,166 | 11.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 249 | 514 | $175,486 | $15,385 | 8.8% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2022 | 181 | 184 | $56,610 | $11,780 | 20.8% |
| 88332 | Pathology examination of specimen during surgery, each additional tissue block | Facility | 2022 | 72 | 284 | $84,424 | $6,916 | 8.2% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 54 | 62 | $47,213 | $6,915 | 14.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 117 | 136 | $32,768 | $3,768 | 11.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 49 | 151 | $28,518 | $3,461 | 12.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 56 | 59 | $19,736 | $1,961 | 9.9% |
| 88323 | Surgical pathology consultation and report on referred material requiring preparation of slides | Facility | 2022 | 21 | 21 | $7,413 | $1,288 | 17.4% |
About Dr. Michelle Williams, M.D
Dr. Michelle Williams, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598793630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Williams, M.D has received a total of $15,681 in payments from pharmaceutical and medical device companies, with $100.12 received in 2024. These payments were reported across 23 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($14,423).
As a Medicare-enrolled provider, Williams has provided services to 4,839 Medicare beneficiaries, totaling 9,079 services with total Medicare billing of $367,594. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Houston, TX
- Active Since 06/29/2006
- Last Updated 10/14/2020
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1598793630
Products in Payments
- Vitrakvi (Drug) $11,490
- TD BenchMark IHC/ISH and Special Stains Reagents (Device) $3,370
- TD VENTANA Primary Staining Instruments and Reagents (Device) $532.29
- KEYTRUDA (Biological) $106.98
- WELIREG (Drug) $73.37
- BRUKINSA (Drug) $29.43
- Optis Coronary Imaging System (Device) $19.34
- SIVEXTRO (Drug) $8.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Houston
Rabia Shafi, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $581,917
Dr. Sanam Loghavi, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $67,988
Aysegul Sahin, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $31,661
Thomas Lohmann, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $30,206
Hong Zhang, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $22,520
Dr. Rashmi Kanagal Shamanna, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $19,575